MHRA switches tranexamic acid
This article was originally published in The Tan Sheet
Executive Summary
The Medicines and Healthcare products Regulatory Agency switches Cyklo-F to treat heavy menstrual bleeding from prescription to nonprescription status in the U.K. Women aged 18 to 45 years with a self-diagnosed history of heavy bleeding over several consecutive menstrual cycles can now obtain tranexamic acid from a pharmacist without a prescription, the U.K. regulator announced March 31
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.